Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

895

Participants

Timeline

Start Date

October 31, 2018

Primary Completion Date

July 30, 2021

Study Completion Date

April 27, 2026

Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
DRUG

olaparib

300 mg (2 x 150 milligrams (mg) tablets) twice daily

DRUG

abiraterone acetate

1000 milligrams (mg) once daily

Trial Locations (132)

2010

Research Site, Darlinghurst

2298

Research Site, Waratah

2747

Research Site, Kingswood

3021

Research Site, St Albans

3128

Research Site, Box Hill

4029

Research Site, Herston

4120

Research Site, Greenslopes

5037

Research Site, Kurralta Park

9000

Research Site, Ghent

10043

Research Site, Orbassano

10408

Research Site, Goyang-si

11042

Research Site, New Hyde Park

11220

Research Site, Brooklyn

13210

Research Site, Syracuse

14076

Research Site, Caen

14642

Research Site, Rochester

17007

Research Site, Girona

19111

Research Site, Philadelphia

20133

Research Site, Milan

20141

Research Site, Milan

25030

Research Site, Besançon

27100

Research Site, Pavia

27710

Research Site, Durham

28041

Research Site, Madrid

28277

Research Site, Bremen

29010

Research Site, Málaga

29107

Research Site, Quimper

29425

Research Site, Charleston

29572

Research Site, Myrtle Beach

34030

Research Site, Istanbul

35209

Research Site, Birmingham

35360

Research Site, Izmir

35575

Research Site, Karşıyaka

40822

Research Site, Mettmann

41009

Research Site, Seville

41404

Research Site, Daegu

47130

Research Site, Jeffersonville

47169

Research Site, Duisburg

48202

Research Site, Detroit

49033

Research Site, Angers

49503

Research Site, Grand Rapids

50968

Research Site, Cologne

51465

Research Site, Bergisch Gladbach

52525

Research Site, Heinsberg

53226

Research Site, Milwaukee

54519

Research Site, Vandœuvre-lès-Nancy

59715

Research Site, Bozeman

60532

Research Site, Lisle

63106

Research Site, St Louis

68130

Research Site, Omaha

69495

Research Site, Pierre-Bénite

70112

Research Site, New Orleans

72622

Research Site, Nürtingen

79106

Research Site, Freiburg im Breisgau

80131

Research Site, Napoli

80211

Research Site, Denver

85704

Research Site, Tucson

85741

Research Site, Tucson

89081

Research Site, Ulm

90027

Research Site, Los Angeles

90073

Research Site, Los Angeles

90419

Research Site, Nuremberg

92123

Research Site, San Diego

92701

Research Site, Šaľa

93611

Research Site, Clovis

95817

Research Site, Sacramento

99503

Research Site, Anchorage

2540488

Research Site, Viña del Mar

4781156

Research Site, Temuco

7500787

Research Site, Santiago

7520349

Research Site, Santiago

07652

Research Site, Paramus

30110-022

Research Site, Belo Horizonte

80810-050

Research Site, Curitiba

60336-232

Research Site, Fortaleza

91350-200

Research Site, Porto Alegre

22793-080

Research Site, Rio de Janeiro

15090-000

Research Site, São José do Rio Preto

01221-020

Research Site, São Paulo

04266-010

Research Site, São Paulo

T2V 1P9

Research Site, Calgary

T6G 1Z2

Research Site, Edmonton

V1Y 5L3

Research Site, Kelowna

B3H 1V7

Research Site, Halifax

N6A 5W9

Research Site, London

M4N 3M5

Research Site, Toronto

M5G 2M9

Research Site, Toronto

J4V 2H1

Research Site, Greenfield Park

H2X 3E4

Research Site, Montreal

H3T 1E2

Research Site, Montreal

656 53

Research Site, Brno

120 00

Research Site, Prague

140 59

Research Site, Prague

150 06

Research Site, Prague

113-8431

Research Site, Bunkyō City

573-1191

Research Site, Hirakata-shi

920-8641

Research Site, Kanazawa

634-8522

Research Site, Kashihara-shi

350-8550

Research Site, Kawagoe-shi

761-0793

Research Site, Kita-gun

606-8507

Research Site, Kyoto

371-8811

Research Site, Maebashi

889-1692

Research Site, Miyazaki

466-8560

Research Site, Nagoya

541-8567

Research Site, Osaka

545-8586

Research Site, Osaka

589-8511

Research Site, Osakasayama-shi

252-0375

Research Site, Sagamihara-shi

285-8741

Research Site, Sakura-shi

160-8582

Research Site, Shinjuku-ku

791-0295

Research Site, Toon-shi

232-0024

Research Site, Yokohama

1213 XZ

Research Site, Hilversum

6525 GA

Research Site, Nijmegen

5042 AD

Research Site, Tilburg

851 05

Research Site, Bratislava

08001

Research Site, Prešov

911 01

Research Site, Trenčín

03080

Research Site, Seoul

03722

Research Site, Seoul

05505

Research Site, Seoul

06591

Research Site, Seoul

08036

Research Site, Barcelona

08035

Research Site, Madrid

01060

Research Site, Adana

06590

Research Site, Ankara

06800

Research Site, Ankara

GU2 7WG

Research Site, Guildford

M20 4BX

Research Site, Manchester

S10 2SJ

Research Site, Sheffield

SO16 6YD

Research Site, Southampton

SA2 8QA

Research Site, Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

AstraZeneca

INDUSTRY